MedPath

ITP block: single or multiple injection?

Phase 1
Conditions
The ITP block is primarily used for pain amelioration after breast cancer surgery.
Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Investigative Techniques [E05]
Registration Number
CTIS2022-501312-34-01
Lead Sponsor
Zealand University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Male
Target Recruitment
12
Inclusion Criteria

Male sex, Age = 18 years at the date of inclusion, American Associations of Anaesthesiologist (ASA) class I-II, Have received thorough information, orally and in written form, and signed the Informed Consent” form on participation in the study., Weight > 52,5 kilograms (chosen due to the international maximal single dose of Ropivacaine (3mg/kg)

Exclusion Criteria

Substantial co-morbidity: American Associations of Anaesthesiologist (ASA) class > II, Daily intake of analgesics (investigators decision), Alcohol and/or drug overuse (investigators decision), Previous thoracic trauma or thoracic surgery, Previous/current piercing of the nipple of any kind on blockade side, Tattoos on the thorax (according to the investigators decision), Any systemic muscular or neuromuscular disease, Any use of vasodilatory substance (investigators decision), Local infection at the site of injection or systemic infection, Difficult sonoanatomical visualisation of the target area (SCTL, ITTC etc.) necessary for the block execution, Severe hypovolemia, Inability to speak and understand Danish, Inability to cooperate, Allergy to study drugs

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath